Pro-haloacetate Nanoparticles for Efficient Cancer Therapy via Pyruvate Dehydrogenase Kinase Modulation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep28196.pdf
Reference40 articles.
1. Bonnet, S. et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37–51 (2007).
2. Welsh, S., Williams, R., Kirkpatrick, L. & Powis, G. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Mol. Cancer Ther. 3, 233–244 (2004).
3. Deus, C. M., Coelho, A. R., Serafim, T. L. & Oliveira, P. J. Targeting mitochondrial function for the treatment of breast cancer. Fut. Med. Chem. 6, 1499–1513 (2014).
4. Gopinath, S. & Evangelos, M. D. Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology. Front. Oncol. 3, 38 (2013).
5. Ruggieri, V. et al. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment. Oncotarget. 6, 1217–1230 (2015).
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanocarbon-Enforced Anisotropic MusCAMLR for Rapid Rescue of Mechanically Damaged Skeletal Muscles;ACS Applied Materials & Interfaces;2023-05-31
2. Use of acidic nanoparticles to rescue macrophage lysosomal dysfunction in atherosclerosis;Autophagy;2022-08-18
3. The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers;Acta Pharmaceutica Sinica B;2021-08
4. Chimeric Drug Design with a Noncharged Carrier for Mitochondrial Delivery;Pharmaceutics;2021-02-12
5. Oligodots: Structurally Defined Fluorescent Nanoprobes for Multiscale Dual-Color Imaging in Vitro and in Vivo;ACS Applied Materials & Interfaces;2020-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3